Bristol Myers Squibb to Participate in Barclays Virtual Global Healthcare Conference Biotech Investing
Knight Therapeutics Announces Canadian Commercial Launch of IBSRELA - New Innovative Treatment for Irritable Bowel Syndrome with Constipation Medical Device Investing
Merck Provides Update on KEYTRUDA® Indication in Metastatic Small Cell Lung Cancer in the US Pharmaceutical Investing
Perimeter Medical Imaging AI Announces U.S. FDA 510 Clearance for OCT Imaging System Medical Device Investing
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
